More than 600 internal medicine doctors from the Spanish Society of Internal Medicine (SEMI) analizan online desde este martes 28 de enero y hasta este viernes 29, en la 15ª Virtual Meeting of the Diabetes, Obesity and Nutrition Working Group (26-29 January) of the Scientific Society, the latest innovations in these camps from the optics of Internal Medicine. In this event, special attention will be paid to the relationship between SARS-CoV-2 infection in diabetes and obesity as risk factors in Covid-19.
Specifically, the virtual program of this virtual meeting, which serves as an interdisciplinary meeting point between internists, endocrinologists, family physicians and other specialists interested in these jobs, will analyze what is affected and what follow the infection of Covid-19 in patients with obesity or diabetes and will have to be the maneuver of these patients.
It is estimated that between 25 and 30 per cent of patients with hospital ingresso by Medicina International diabetes. In addition, there are 50 per cent of patients who ingested cardiovascular disease also present this problem as underlying pathology.
‘Prevalence of cardiovascular disease in diabetic and progressive patients. It is estimated that there are 60 per cent of patients who have had diabetes since they were 15 years old, or the cardiovascular association affecting it, ”indicates Francisco Javier Carrasco, coordinator of the Group of Diabetes Work, Obesity and Nutrition of the SEMI and Internal Medicine of the Internal Medicine Service of the Hospital Juan Ramón Jiménez de Huelva.
Internal medicine, as a hospital specialist in the patient’s integral way, and diabetic patient in the vascular risk mark, since the diabetes develops a papel deurslaggewend in patients with high vascular risk and the adequate control of diabetes is fundamental to avoid systemic characterization complications, mainly peripheral arterial disease, cardiac or renal involvement, among others.
Among other topics, in the virtual meeting, in addition to addressing cardiovascular and renal diabetes, will be presented the update of 2021 Diabetes type 2 (DM2) diabetes treatment algorithm analyzes Covid-19 patient, as well as pautas and recommendations in esteroid diabetes.
Also discussed about the attention, care and treatment of the frail patient, with special attention to the role of clinical nutrition in its functional recovery and how to treat the pandemic in these patients.
Hyperglycemia and Covid-19
In a specific way, in a virtual meeting we analyze the Clinical implications of hyperglycemia in SARS-CoV-2 infection and will have to go overboard. Según este estudio del Registro SEMI-Covid-19 with data of 11,312 patients, hyperglycemia (independence from the antecedent diabetes) as asocia a burgemeester necesidad de ventilación mecánica, ingreso en UCI y riesgo de muerte en contexto Covid-19
Following the halls of this studio, the Probability of accumulating mortality significantly mayor in patients with hyperglycemia in comparison with patients with normoglucemia, Independently of the presence of diabetes. Of the 11,312 patients, only 2,128 (18.9 per cent) had diabetes and 2,289 (20.4 per cent) failed during hospitalization. Hospital 15 death rates increase by 15.7 per patient for patients with glucemia <140 mg/dl, del 33,7% para aquellos con 140-180 mg/dl y del 41,1 por ciento para pacientes con > 180 mg / dl of glycemia.
Thus, hyperglucemia espdespues to adjust parameters for edema, diabetes, hypertension, and other confusion factors. mortality risk independent factor and, in addition, also associated, as it was associated with anteriority, with mayor requiring mechanical ventilation, entry into UCI and mortality.
Although it contains statements, dates or appointments of institutions or health care professionals, the information contained in Redacción Médica is edited and elaborated by periodicals. We recommend to the reader that any relationship with the health be consulted with a health care professional.